AstraZeneca and Bristol Myers Squibb potential merger
The developments in this story so far, most recent first.
-
· date approximate Breaking
AstraZeneca and Bristol Myers Squibb in merger discussions, FT reports
-
· date approximate Background
AstraZeneca and Bristol Myers Squibb have been discussing a merger over the last few months.
The Financial Times reported that UK-based AstraZeneca and US competitor Bristol Myers Squibb telah been discussing a merger over the last few months.
According to reports, the proposed merger would result in a joint company valued at approximately $400 billion and would stand as one of the largest in history. Neither AstraZeneca nor Bristol Myers Squibb immediately responded to requests for comment regarding these discussions.